Skip to main content

Table 1 Clinical characteristics of studied subjects

From: Association of NOS3 (rs 2070744) and SOD2Val16Ala (rs4880) gene polymorphisms with increased risk of ESRD among Egyptian patients

  CKD (n = 16) ESRD (n = 100) Control (n = 100) P value
Gender   0.004
Female 8 (50%) 31 (31%) 54 (54%)
Male 8 (50%) 69 (96%) 46 (46%)
  Mean ± SD Mean ± SD Mean ± SD
Age 40.88 ± 11.10 47.10 ± 16.11 37.84 ± 12.73 < 0.001
HB conc. 16.04 ± 24.54 10.10 ± 1.96 12.31 ± 1.26 0.002
Creatinine conc. 3.69 ± 5.16 8.08 ± 3.03 0.82 ± 0.20 < 0.001
Bilirubin 0.47 ± 0.14 0.63 ± 0.20 0.40 ± 0.13 < 0.001
SGPT 30.0 ± 4.40 27.06 ± 21.85 21.06 ± 8.61 0.012
SGOT 38.63 ± 3.70 30.40 ± 21.19 29.38 ± 9.01 0.094
Ca 9.18 ± 0.80 8.27 ± 1.14 < 0.001
P 3.34 ± 0.58 5.98 ± 2.40 < 0.001
PTH 31.30 ± 11.3 477.54 ± 439.73 < 0.001
HBs Ag Negative 16 (100.0%) 100 (100.0%) 0 (0.0%) NA
HCV Negative 16 (100%) 74 (74%) 100(100%) < 0.001
  Positive 0 (0%) 26 (26%) 0 (0%)
FBS 106.56 ± 43.58 125.5 ± 67.59   0.279
Urea 107.75 ± 30.36    
GFR 28.75 ± 13.91